Clinical and Commercial Stage Assets for Rare Indications
Vanderbilt University
Vanderbilt University is seeking rare indication assets for portfolio expansion
Reference No.
RFP-2025-3128
Category
Healthcare/Medical
Due Date
December 9th, 2025
Description
A mid-cap publicly traded US pharmaceutical company specializing in rare diseases is seeking to expand their portfolio with clinical-stage and commercial assets.
Key Requirements
RFP Submission Requirements for Vanderbilt Rare Assets
Contact Information
What you’ll get when you unlock
All the details after a short form. No spam
- Latest RFP PDF
- Buyer contact sheet
- Submission checklist
- Any addenda links